NCT03556995 is a clinical trial of bariatric surgery patients in Obesity, sponsored by Assuta Medical Center.

Who is sponsoring NCT03556995?

NCT03556995 is sponsored by Assuta Medical Center.

What drugs are being tested in NCT03556995?

Interventions in NCT03556995: bariatric surgery patients.

What condition does NCT03556995 study?

NCT03556995 studies Obesity, Bariatric Surgery Candidate, Complication, Bleeding.

Is NCT03556995 still recruiting?

NCT03556995 is currently completed. Last updated 18 June 2018.

Last reviewed 2018-06-18 · How we verify

NCT03556995

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Suggesting Score Scale for Risk of Bleeding in Bariatric Surgery

Completed Last updated 18 June 2018

What this trial tests

trial testing bariatric surgery patients in Obesity in 9,044 participants. Completed in 31 January 2018.

Timeline

1 January 2013

Primary endpoint
31 March 2016

31 January 2018

Quick facts

Lead sponsor	Assuta Medical Center
Status	Completed
Study type	OBSERVATIONAL
Enrollment	9,044
Start date	1 January 2013
Primary completion	31 March 2016
Estimated completion	31 January 2018
Sites	1 location across Israel

Drugs / interventions tested

bariatric surgery patients

Conditions studied

Obesity — all drugs for Obesity →
Bariatric Surgery Candidate — all drugs for Bariatric Surgery Candidate →
Complication — all drugs for Complication →
Bleeding — all drugs for Bleeding →

Sponsor

Assuta Medical Center

Who can join

18 and older, any sex, with Obesity or Bariatric Surgery Candidate. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

As bleeding is a major risk in bariatric surgeries, we aimed our study to find any predictors to such bleeding within the surgery or 30 days after surgery. The study is a retrospective study collecting patients data, surgeons data, and hospitals data in order to find if any of the factors influencing patients, surgeons or hospitals, has to do with bleeding in these surgeries and if it does impact bleeding in what way. The goal is finding a predictor that it's neutralizing may prevent bleeding in bariatric surgeries.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Obesity

Currently open trials in the same condition.

NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting

Other Assuta Medical Center trials

Trials by the same sponsor.

NCT06950684 — Impact of Protein Supplementation and Resistance Training on Body Composition, Functional Parameters, Metabolic Adaptati · NA · not yet recruiting
NCT05122013 — Remote Intervention for Weight Regain After Sleeve Gastrectomy · NA · completed
NCT04741113 — The Effect of an Education Module to Reduce Weight Bias Among Healthcare Professionals in a Private Hospital Setting · NA · completed
NCT04451499 — The Effect of Adding Smartphone-based Platform to the Bariatric Surgery Preparation Process · NA · completed
NCT05134389 — Survey on GI and Nutritional Parameters Among OAGB Patients From Different Countries · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03556995 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assuta Medical Center
Last refreshed: 18 June 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03556995.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing